Scoping Review Maps Osteoporosis Care After Distal Radius Fracture

A scoping review of 250 reports examined osteoporosis assessment and treatment after distal radius fracture in adults aged 50 and older. Observational reports associated post-fracture care with fewer subsequent fractures, but the evidence was heterogeneous and no fracture-specific randomized trial or direct comparison of early versus delayed treatment was identified.

Review included 250 reports on osteoporosis care after wrist fracture.
Median DXA testing and treatment initiation were 26% and 22%.
No study directly compared early versus delayed treatment.
Fracture benefit in normal-BMD patients remains unclear.

Distal radius fracture (DRF) can be an early fragility fracture, but evidence on osteoporosis evaluation and treatment afterward is unclear. This JBI-guided scoping review, reported under PRISMA-ScR and prospectively registered on OSF, searched seven databases for reports involving adults aged 50 or older with DRF or wrist fragility fracture. The authors identified 250 reports published from 2008 to 2026 and synthesized findings descriptively without pooling estimates.

The evidence covered bone mineral density (BMD)-based risk assessment and treatment selection (103 reports), gaps in care (65), prognosis (40), and treatment (42). Median DXA testing and treatment-initiation rates were 26% and 22%, respectively. Eleven observational reports linked treatment or structured care with fracture outcomes; a separate economic model projected outcomes. Results varied, and no study directly compared early with delayed treatment after DRF using subsequent fracture as the outcome.

Only six reports focused on patients with normal BMD, and none estimated fracture outcomes specifically for this subgroup. The review supports attention to secondary fracture prevention after DRF, but observational associations do not establish a causal treatment effect. Optimal treatment timing and benefit for patients with normal BMD remain uncertain.

In practice

For adults aged 50 or older with a distal radius fracture, the review highlights low rates of DXA testing and treatment initiation and supports attention to osteoporosis assessment and secondary prevention. It reports that DXA and FRAX can inform individualized decisions and that indicated care should not be delayed for testing. However, the evidence is largely observational: no DRF-specific randomized trial or direct comparison of early versus delayed treatment was identified, and fracture outcomes in patients with normal BMD remain unresolved. The review does not establish a causal treatment effect or an optimal timing strategy.

AI-generated clinical interpretation · Not editor-reviewed

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Source

Osteoporosis International: Clinical role and timing of osteoporosis evaluation and treatment after distal radius fracture: a scoping review ↗

This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.